Injectable / Growth Hormone & Performance
Follistatin (FLGR242)
Myostatin Inhibitor · 10mg
$1,899 USD per unit · Coming soon · 10mg / 2mL vial
Recombinant follistatin variant that binds and neutralizes myostatin, the primary negative regulator of muscle growth. The most direct approach to muscle mass optimization.
Product information
Follistatin is a naturally occurring glycoprotein that binds to and inhibits the activity of myostatin, the master negative regulator of skeletal muscle growth. FLGR242 is a recombinant follistatin variant engineered for enhanced stability and bioavailability, delivering the most direct pharmacological approach to overriding genetic muscle mass limitations.
Myostatin acts as a biological brake on muscle growth, its inhibition via follistatin removes this constraint, allowing muscle hypertrophy to proceed beyond typical genetic thresholds. Research in both animal and human models demonstrates significant increases in lean muscle mass with follistatin therapy. This represents the frontier of muscle optimization science, with applications ranging from athletic performance to age-related sarcopenia prevention.
Benefits
- Direct myostatin neutralization
- Genetic muscle mass limitation override
- Lean tissue accrual support
- Anti-sarcopenia applications
- No androgenic side effects
- Recombinant pharmaceutical-grade formulation
Specifications
- Fill / pack
- 10mg / 2mL vial
- Format
- Injectable
- Serving
- Per protocol
- Servings per container
- Varies by protocol
- Listed purity
- 99.4%
- Molecular weight / composition
- ~37,800 Da (FLGR242 variant)
- Storage
- Refrigerate 2-8°C
For laboratory and research use only. Not for human consumption.
Browse all peptide bioregulators or the Growth Hormone & Performance collection. All formulations.